PRKG1-AS1: A Potential Drug Target and Biomarker (G100506939)

Target Name: PRKG1-AS1

NCBI ID: G100506939

PRKG1-AS1

Other Name(s): PRKG1 antisense RNA 1

PRKG1-AS1: A Potential Drug Target and Biomarker

Primatekaput (PRKG1) is a gene that encodes a protein known as AS1. AS1 is a key regulator of the growth and differentiation of epithelial cells, which form the lining of various body surfaces and organs. The dysfunction of AS1 has been implicated in various diseases, including cancer, skin disorders, and developmental defects. PRKG1-AS1 has been identified as a potential drug target and biomarker for several diseases, including cancer.

The identification of PRKG1-AS1 as a potential drug target comes from a study that identified its role in the regulation of cell growth and differentiation. The study showed that high levels of PRKG1-AS1 were associated with the growth and survival of cancer cells, while low levels were associated with the inhibition of cell growth and the apoptosis of cancer cells. Additionally, the study identified that PRKG1-AS1 was expressed in various types of cancer, including lung, breast, and ovarian cancer.

The potential use of PRKG1-AS1 as a drug target is based on its ability to regulate cell growth and differentiation, as well as its expression in various types of cancer. PRKG1-AS1 can be targeted by small molecules, such as drugs, to inhibit its function and prevent cancer cell growth. This holds great promise for the development of new cancer therapies.

As a biomarker, PRKG1-AS1 can be used to diagnose and monitor the effectiveness of cancer therapies. For example, the levels of PRKG1-AS1 can be used to assess the effectiveness of a drug in inhibiting cancer cell growth. Additionally, PRKG1-AS1 levels can be used to track the progression of cancer, as its levels may be reduced in cancer cells that are more resistant to the drug.

In conclusion, PRKG1-AS1 is a potential drug target and biomarker for cancer. Its ability to regulate cell growth and differentiation, as well as its expression in various types of cancer, makes it an attractive target for small molecules. Further research is needed to fully understand the role of PRKG1-AS1 in cancer and its potential as a drug.

Protein Name: PRKG1 Antisense RNA 1

The "PRKG1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRKG1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets